CASC2 and metastatic malignant neoplasm in the lymph nodes: We found that CASC2 levels were significantly associated with tumor differentiation, lymph node metastasis, and TNM stage, but not correlated with age, gender, tumor size, smoking status and tumor location (Table 1).